Fidelity Clinical Research Inc is categorized under Medical Research in Fort Lauderdale, FL and active since 2009.
Fidelity Clinical Research Inc was established in 2009, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Scott Segal at the company’s single location by writing to 7481 West Oakland # 100, Fort Lauderdale, Florida FL 33319 or by phoning (954) 749-9229. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Fidelity Clinical Research Inc |
| Contact Person: | Scott Segal |
| Address: | 7481 West Oakland # 100, Fort Lauderdale, Florida 33319 |
| Phone Number: | (954) 749-9229 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Fidelity Clinical Research Inc was started in 2009 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Scott Segal for inquiries that concern Fidelity Clinical Research Inc by calling the company number (954) 749-9229, as your correspondence is most welcome. Additionally, the physical location of the single location of Fidelity Clinical Research Inc can be found at the coordinates 26.166217,-80.247798 as well as the street address 7481 West Oakland # 100 in Fort Lauderdale, Florida 33319.
For its online presence, you may visit Fidelity Clinical Research Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.